Wednesday, January 10, 2018 10:16:08 PM
Just wanted to add this as it's funny.
"For the quarter ending June 30th 2017, Easton through its host company Ackerman Pharma, received $400,000 in product purchase orders for the products Gynofit and advanced payment for product AmnioSense (AL - Sense) from its sub - distribution partner Gedeon Richter Plc and its subsidiary company. This sale has been reversed as the product has not been delivered nor paid for."
The bartender/waitress is the Chief Financial Officer now. Great!
As per last fins.
Promissory note(s) $1,588,035
Any guesses what those terms are for a zero revenue company? Just wondering. I am confident that they are in the best interests of the shareholders imo.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM